News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
Presentation TCT 2022 Have We Gotten to the Final Word on Paclitaxel Safety? Presenter: Eric Secemsky September 17, 2022
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
Presentation TCT 2012 Use Of Paclitaxel-Eluting Stents Reduces Target Lesion Revascularization for Dialysis Patients. Presenter: Hirotoshi Watanabe, Kyohei Yamaji, Yoshimitsu Soga, Shinichi Shirai, Kenji Ando, Koyu Sakai, Katsuhiro Kondo, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi January 03, 2012